|
Market Closed -
Nasdaq
21:00:00 18/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.3119 USD | -6.48% |
|
-2.65% | -68.81% |
| 03:51am | TScan Therapeutics, Inc.(NasdaqGM:TCRX) dropped from S&P Global BMI Index | CI |
| 09-02 | Needham Downgrades TScan Therapeutics to Hold From Buy | MT |
| Market Cap | 21.14M 18.43M 17.41M 15.81M 29.61M 2.03B 29.74M 209M 80.46M 1.03B 79.41M 77.65M 3.32B | P/E 2026 * |
-0.39x | P/E 2027 * | -0.52x |
|---|---|---|---|---|---|
| Enterprise Value | -77.73M -67.78M -64M -58.11M -109M -7.46B -109M -767M -296M -3.79B -292M -285M -12.2B | EV / Sales 2026 * |
-17.3x | EV / Sales 2027 * | -16.4x |
| Free-Float |
93.51% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| TCRX | Delayed | |
CBOE
| TCRX | Real-time |
Last Transcript: TScan Therapeutics, Inc.
| 1 day | -6.48% | ||
| 1 week | -2.65% | ||
| Current month | -57.26% | ||
| 1 month | -59.82% | ||
| 3 months | -66.10% | ||
| 6 months | -70.01% | ||
| Current year | -68.81% |
| 1 week | 0.29 |  | 0.36 |
| 1 month | 0.29 | | 0.81 |
| Current year | 0.29 | | 1.47 |
| 1 year | 0.29 | | 2.57 |
| 3 years | 0.29 | | 9.69 |
| 5 years | 0.29 | | 9.69 |
| 10 years | 0.29 | | 14.71 |
| Manager | Title | Age | Since |
|---|---|---|---|
Gavin MacBeath
CEO | Chief Executive Officer | 56 | 27/03/2023 |
Dawn Pinchasik
CTO | Chief Tech/Sci/R&D Officer | - | 05/02/2024 |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Katina Dorton
BRD | Director/Board Member | 68 | 22/03/2021 |
Gavin MacBeath
BRD | Director/Board Member | 56 | 23/05/2023 |
Stephen Biggar
CHM | Chairman | 55 | 11/06/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 20/05/26 | Free | Director | 67,000 | 0.1200% | ||
| 20/05/26 | Free | Director | 67,000 | 0.1200% | ||
| 20/05/26 | Free | Director | 67,000 | 0.1200% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -6.48% | -2.65% | -82.58% | -89.02% | 21.14M | |
| -0.31% | +5.79% | +47.13% | +99.53% | 70.88B | |
| -0.80% | -0.44% | +36.88% | +82.43% | 62.49B | |
| +5.26% | +7.86% | +32.24% | +30.06% | 26.34B | |
| -3.21% | -7.27% | -17.10% | +370.22% | 26.21B | |
| -2.64% | -0.69% | -0.17% | -11.56% | 24.13B | |
| -1.15% | +5.62% | +23.11% | -12.42% | 20.72B | |
| +2.12% | -5.86% | +161.58% | +333.73% | 15.69B | |
| -0.22% | +3.99% | +45.54% | +171.32% | 14.46B | |
| +0.73% | +1.71% | -5.51% | +859.68% | 14.24B | |
| Average | -0.67% | +1.30% | +24.11% | +183.40% | 27.52B | |
| Weighted average by Cap. | -0.25% | +1.49% | +35.01% | +153.05% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.51M 3.93M 3.71M 3.37M 6.31M 432M 6.34M 44.43M 17.15M 220M 16.92M 16.55M 707M | 3.28M 2.86M 2.7M 2.45M 4.59M 314M 4.61M 32.32M 12.47M 160M 12.31M 12.04M 514M |
| Net income | -105M -91.44M -86.34M -78.4M -147M -10.06B -148M -1.03B -399M -5.12B -394M -385M -16.46B | -79.1M -68.98M -65.13M -59.14M -111M -7.59B -111M -780M -301M -3.86B -297M -291M -12.42B |
| Net Debt | -98.87M -86.21M -81.4M -73.92M -138M -9.49B -139M -975M -376M -4.82B -371M -363M -15.52B | -74.76M -65.19M -61.55M -55.89M -105M -7.17B -105M -737M -285M -3.65B -281M -275M -11.73B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/09/26 | US$0.3119 | -6.48% | 1,143,331 |
| 17/09/26 | US$0.3335 | +0.76% | 1,096,263 |
| 16/09/26 | US$0.3310 | +3.02% | 884,124 |
| 15/09/26 | US$0.3213 | +4.90% | 679,168 |
| 14/09/26 | US$0.3063 | -4.40% | 1,103,954 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TCRX Stock
Select your edition
All financial news and data tailored to specific country editions
